Products & Services



  • 尊龙凯时AG(中国区)官方网站

    Search

    Filters

    Commercialized//Validated

    Under validation

    Under development

    PDF

    Download Product list

    clear all filters

    Name

    Structure

    CAS No.

    Quality Standard
    Application
    status

    Apalutamide
    956104-40-8
    In house
    Prostate cancer
    Commercialized//Validated

    Apixaban
    503612-47-3
    In house
    Anticoagulant
    Commercialized//Validated

    Avatrombopag maleate
    570406-98-3
    In house
    Antithrombocytopenics
    Commercialized//Validated

    Azilsartan
    147403-03-0
    In house
    Antihypertensive
    Commercialized//Validated

    Azilsartan medoxomil potassium
    863031-24-7
    In house
    Antihypertensive
    Commercialized//Validated

    Brexpiprazole
    913611-97-9
    In house
    Antidepressants
    Commercialized//Validated

    Brivaracetam
    357336-20-0
    In house
    Antiepileptic
    Commercialized//Validated

    Cabozantinib malate
    1140909-48-3
    In house
    Anticancer
    Commercialized//Validated

    Canagliflozin hemihydrate
    928672-86-0
    In house
    SGL2 Inhibitor/Antidiabetic
    Commercialized//Validated

    Candesartan cilexetil
    145040-37-5
    USP/EP
    Antihypertensive
    Commercialized//Validated

    Dabigatran etexilate mesylate
    872728-81-9
    In house
    Anticoagulant
    Commercialized//Validated

    Dapagliflozin
    960404-48-2
    In house
    SGL2 Inhibitor/Antidiabetic
    Commercialized//Validated

    Edoxaban tosylate monohydrate
    1229194-11-9
    In house
    Anticoagulant
    Commercialized//Validated

    Elagolix sodium
    832720-36-2
    In house
    Pain due to endometriosis
    Commercialized//Validated

    Empagliflozin
    864070-44-0
    In house
    SGL2 Inhibitor/Antidiabetic
    Commercialized//Validated

    Enzalutamide
    915087-33-1
    In house
    Anticancer
    Commercialized//Validated

    Ezetimibe
    163222-33-1
    USP
    Cholesterol Absorption Inhibitor
    Commercialized//Validated

    Febuxostat
    144060-53-7
    In house
    Antihypercholesterolemic,Antigout
    Commercialized//Validated

    Ibrutinib
    138402-11-6
    In house
    Antihypertensive
    Commercialized//Validated

    Irbesartan
    936563-96-1
    USP/EP
    Antiallergic, Anticancer
    Commercialized//Validated

    Losartan potassium
    124750-99-8
    USP/EP
    Antihypertensive
    Commercialized//Validated

    Montelukast sodium
    151767-02-1
    USP/EP
    Antiasthma
    Commercialized//Validated

    Nicorandil
    65141-46-0
    JP/EP
    Anti angina pectoris
    Commercialized//Validated

    Olmesartan medoxomil
    144689-63-4
    USP/EP
    Antihypertensive
    Commercialized//Validated

    Oteseconazole
    1340593-59-0
    In house
    Antifungal
    Commercialized//Validated

    Pregabalin
    148553-50-8
    In house
    Antiepileptic
    Commercialized//Validated

    Rivaroxaban
    366789-02-8
    EP
    Anticoagulants
    Commercialized//Validated

    Sacubitril Valsartan Sodium
    936623-90-4
    In house
    Antihypertensive
    Commercialized//Validated

    Silodosin
    160970-54-7
    JP/In house
    Benign prostatic hyperplasia
    Commercialized//Validated

    Sitagliptin hydrochloride monohydrate
    862156-92-1
    In house
    Antidiabetic
    Commercialized//Validated

    Sitagliptin phosphate monohydrate
    654671-77-9
    USP/EP
    Antidiabetic
    Commercialized//Validated

    Tafluprost
    209860-87-7
    In house
    Antiglaucoma
    Commercialized//Validated

    Telmisartan
    144701-48-4
    USP/EP
    Antihypertensive
    Commercialized//Validated

    Ticagrelor
    274693-27-5
    EP
    Antiplatelet
    Commercialized//Validated

    Valsartan
    137862-53-4
    USP/EP
    Antihypertensive
    Commercialized//Validated

    Vildagliptin
    274901-16-5
    In house
    Antidiabetic
    Commercialized//Validated

    Vonoprazan fumarate
    881681-01-2
    In house
    Antiulcer
    Commercialized//Validated

    Dapagliflozin Free Base
    461432-26-8
    In house
    Antidiabetic
    Commercialized//Validated

    Relugolix
    737789-87-6
    In house
    Endometriosis
    Commercialized//Validated

    Finerenone
    1050477-31-0
    Diabetic nephropathy
    Under validation

    Bilastine
    202189-78-4
    Antihistamine
    Under validation

    Mirogabalin Besylate
    1138245-21-2
    Analgesic
    Under validation

    Nebivolol Hydrochloride
    152520-56-4
    Antihypertensive
    Under validation

    Abemaciclib
    1231929-97-7
    Anticancer
    Under validation

    Vibegron
    1190389-15-1
    Overactive bladder 
    Under validation

    Ribociclib Succinate**
    1374639-75-4
    Anticancer
    Under development

    Aprocitentan**
    1103522-45-7
    Antihypertensive
    Under development

    Elacestrant Dihydrochloride**
    1349723-93-8
    Anticancer
    Under development

    Upadacitinib*
    2050057-56-0
    Antiarthritic
    Under development

    Acalabrutinib *
    1420477-60-6
    Anticancer
    Under development

    Darolutamide*
    1297538-32-9
    Anticancer
    Under development

    Alectinib Hydrochloride*
    1256589-74-8
    Anticancer
    Under development

    Bempedoic Acid*
    CAS(游离碱) 738606-46-7 CAS(盐) N/A
    Antilipemic
    Under development

    Resmetirom*
    CAS(游离碱) 920509-32-6
    Nonalcoholic Steatohepatitis
    Under development

    Ruxolitinib Phosphate
    CAS(游离碱):941678-49-5 CAS(盐):1092939-17-7
    Antimyelofibrosis
    Under development

    Ritlecitinib Tosilate
    2192215-81-7
    Antialopecia
    Under development

    Pirtobrutinib
    2101700-15-4
    Anticancer
    Under development

    Ribociclib Succinate
    1374639-75-4
    Anticancer
    Under development

    Contact Information

    China Sales Center
    Tel:+86 (0)576-89189675
    Email: tianyu@rkysy.com
    Latin America Market
    Tel:+86 (0)576-89189685
    Email:ok@rkysy.com
    Europe&North America
    Market
    Tel:+86 (0)576-89189306
    Email:hhy@rkysy.com
    Row Market(CIS、Turkey、Africa、etc.)
    Tel:+86 (0)576-89189688
    Email:pb@rkysy.com
    CDMO Service & BD
    Tel:+86 (0)21 61917986
    Email:cdmo@rkysy.com
    bd@rkysy.com
    RESPONSIBILITY
    Share Contact Information, Store Details, And
    Brand Content With Your Customers.
    浙江 © 2024 尊龙凯时AG药业股份有限公司. 浙ICP备09027697号 浙公网安备33100302000925号 由 极简慕枫 Support
    Hi! Cookies statement
    Tianyu Pharmaceutical attaches great importance to your personal privacy. When you visit our website http://tyyy.mfdemo.cn/ Please agree to use all cookies. If you would like to learn more about how we use cookies, please visit our privacy policy
    Accept
    Only accept necessary cookies